The MTHFR Ala222Val and Glu429Ala polymorphisms have been found to be a risk factor for a variety of cancers including colon cancer (11), acute lymphoblastic leukemia (12), gastric cancer (13) and head and neck squamous cell carcinoma (14). Here, MTHFR is linked to malignant colon neoplasm.